| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023509 |
| Receipt No. | R000027079 |
| Official scientific title of the study | Effects of Kihito on cognitive functions in Alzheimer's disease patients |
| Date of disclosure of the study information | 2016/08/22 |
| Last modified on | 2018/09/18 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effects of Kihito on cognitive functions in Alzheimer's disease patients | |
| Title of the study (Brief title) | Effects of Kihito on cognitive functions in Alzheimer's disease patients | |
| Region |
|
|
| Condition | |||||
| Condition | Alzheimer's disease | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Others | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | Investigation of cognitive functions at pre and post (16 weeks after) administration of Kampo medicine, Kihito. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | At the pre and post (for 16 weeks) administration of kKihito, these tests of cognitive functions are done; Mini Mental State Examination (MMSE)and Repeatable Battery for the Assessment (RBANS). |
| Key secondary outcomes | analysis of the blood |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Only Cholinesterase inhibitor (aricept, for 16 weeks - Cholinesterase inhibitor plus Kihito for 16 weeks
*without washout period *Tsumura Kihito (2.5 g in package; 3 packages/day) |
|
| Interventions/Control_2 | Cholinesterase inhibitor plus Kihito for 16 weeks - Only Cholinesterase inhibitor (aricept, for 16 weeks
*without washout period *Tsumura Kihito (2.5 g in package; 3 packages/day) |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Adults living in Toyama prefecture, who was diagnosed as Alzheimer's disease by cognitive testa and image analyses, and has taken any cholinesterase inhibitor more than 6 months. Score of MMSE in the person is above 15 points. | |||
| Key exclusion criteria | Persons whose MMSE score is below 14 points. | |||
| Target sample size | 24 | |||
| Research contact person | |
| Name of lead principal investigator | Chihiro Tohda |
| Organization | University of Toyama |
| Division name | Division of Neuromedical Science, Institute of Natural Medicine |
| Address | 2630 Sugitani, Toyama, 930-0194, JAPAN |
| TEL | 076-434-7646 |
| chihiro@inm.u-toyama.ac.jp | |
| Public contact | |
| Name of contact person | Chihiro Tohda |
| Organization | University of Toyama |
| Division name | Division of Neuromedical Science, Institute of Natural Medicine |
| Address | 2630 Sugitani, Toyama, 930-0194, JAPAN |
| TEL | 076-434-7646 |
| Homepage URL | |
| chihiro@inm.u-toyama.ac.jp | |
| Sponsor | |
| Institute | University of Toyama |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Toyama |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立大学法人 富山大学 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027079 |